RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
STVZX
Price
$10.06
Change
-$2.43 (-19.46%)
Updated
Dec 18 closing price
Ad is loading...

RMFCX vs STVZX

Header iconRMFCX vs STVZX Comparison
Open Charts RMFCX vs STVZXBanner chart's image
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
Virtus Ceredex Large-Cap Value Equity R6
Price$10.06
Change-$2.43 (-19.46%)
VolumeN/A
CapitalizationN/A
RMFCX vs STVZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. STVZX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and STVZX is a StrongSell.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. STVZX (623M). RMFCX (1.69) and STVZX (1.66) have matching dividends . RMFCX was incepted earlier than STVZX: RMFCX (23 years) vs STVZX (10 years). STVZX is a more actively managed with annual turnover of: 132.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than STVZX: RMFCX (250) vs STVZX (2500000). STVZX annual gain was more profitable for investors over the last year : 13.99 vs. RMFCX (9.39). RMFCX return over 5 years is better than : 36.51 vs. STVZX (-3.98).
RMFCXSTVZXRMFCX / STVZX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD8.89613.47666%
Front LoadN/AN/A-
Min. Initial Investment25025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets98.7B623M15,843%
Annual Yield % from dividends1.691.66102%
Returns for 1 year9.3913.9967%
Returns for 3 years11.57-18.66-62%
Returns for 5 years36.51-3.98-916%
Returns for 10 years58.17-15.91-366%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc